All billsEnactedEnactedStage not suppliedStage not supplied
H.Con.Res. 158·111th Congress·House Concurrent Resolution
Expressing support for the designation of an Early Detection Month for breast cancer and all forms of cancer.
Stage not supplied
The source supplies the latest action, but no lifecycle stage.
Latest action (24 Feb 2010): Message on Senate action sent to the House.
What this bill does
Plain-English summary
Generate a neutral, plain-English explanation of what this bill does, who it affects and what happens next — grounded in the official text.
Timeline
24 Feb 2010
Message on Senate action sent to the House.
Common questions
- What does H.Con.Res. 158 do?
- H.Con.Res. 158, "Expressing support for the designation of an Early Detection Month for breast cancer and all forms of cancer.," is a House Concurrent Resolution in the 111th Congress. Its full text has not been published yet, so only its stated purpose, sponsor and status are known so far.
- Has H.Con.Res. 158 become law?
- The source does not supply a confirmed lifecycle stage for H.Con.Res. 158. Check the latest action and official source below.
- Who sponsored H.Con.Res. 158?
- H.Con.Res. 158 was sponsored by Rep. Etheridge, Bob [D-NC-2] (D-NC), with 51 cosponsors.
- What's the latest action on H.Con.Res. 158?
- Message on Senate action sent to the House. (24 Feb 2010).
Related bills in Health
H.R. 1703·119th Congress
Choices for Increased Mobility Act of 2026
Rep. Joyce, John [R-PA-13]HealthLast action 10 Nov 2026
H.R. 8205·119th Congress
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Rep. Quigley, Mike [D-IL-5]HealthLast action 3 Nov 2026
H.R. 10798·119th Congress
Silicosis Prevention and Treatment Act
Rep. Correa, J. Luis [D-CA-46]HealthLast action 13 Oct 2026
H.R. 10788·119th Congress
Lower Premiums, Faster Payments Act
Rep. Pallone, Frank [D-NJ-6]HealthLast action 9 Oct 2026
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.